PET/MR Imaging in the Detection and Characterization of Pulmonary Lesions: Technical and Diagnostic Evaluation in Comparison to PET/CT

被引:94
|
作者
Rauscher, Isabel [1 ]
Eiber, Matthias [1 ]
Furst, Sebastian [2 ]
Souvatzoglou, Michael [2 ]
Nekolla, Stephan G. [2 ]
Ziegler, Sibylle I. [2 ]
Rummeny, Ernst J. [1 ]
Schwaiger, Markus [2 ]
Beer, Ambros J. [2 ]
机构
[1] Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-81675 Munich, Germany
[2] Tech Univ Munich, Dept Nucl Med, D-81675 Munich, Germany
关键词
positron emission tomography; magnetic resonance imaging; computed tomography; hybrid imaging; pulmonary lesion; ATTENUATION CORRECTION; NODULES; SCANNER; PERFORMANCE; CHEST; MRI; CT; TOMOGRAPHY; ACCURACY; PILOT;
D O I
10.2967/jnumed.113.129247
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Fully integrated PET/MR imaging holds great promise as a novel hybrid imaging modality in oncology and might offer advantages to PET/CT in many instances, especially because of the superior soft-tissue contrast of MR imaging, compared with CT. However, lung metastases are a frequent finding in oncologic patients, and for imaging of the lung CT is still the modality of choice. Thus, we prospectively evaluated differences in quality, detection rate, size, and radiotracer uptake of pulmonary lesions in F-18-FDGPET/CT and PET/ MR imaging. Methods: Institutional review board approval and informed consent were obtained. Forty patients (23 men, 17 women; mean age +/- SD, 53.2 +/- 13.1 y) underwent a single-injection dual-imaging protocol with F-18-FDGPET/CT and PET/ MR imaging. Pulse sequences for the lung included T1-weighted VIBE (volumetric interpolated breath-hold examination) Dixon for attenuation correction and contrast-enhanced VIBE pulse sequences. All patients underwent a diagnostic CT of the chest in deep inspiration, which also served as a standard of reference. Two masked readers assessed in consensus all images randomly concerning quality, detection, standardized uptake value (SUV), and size of pulmonary nodules. Correlations were performed using linear correlation. Results: Overall, 47 pulmonary lesions (mean size +/- SD, 10.0 +/- 11.4mm; range, 2-60mm) in 25 of 40 patients were detected. The PET datasets of PET/ MR imaging and PET/ CT revealed 22 of 47 pulmonary lesions with focal F-18-FDG uptake. SUVs of lung lesions in PET/ MR imaging and PET/ CT correlated significantly (R = 0.9; P = 0.0001) and showed no significant difference (mean SUV PET/ MR imaging, 6.3; PET/ CT, 5.1; P = 0.388). There was a significantly lower image quality comparing Dixon and VIBE sequence with CT whereas PET from PET/ CT and PET from PET/ MR imaging showed the same results (2.8). Dixon images detected 15 of 47 lung lesions whereas VIBE images detected 32 of 47 lesions, respectively. The detection rates for small lung lesions less than 1 cm in diameter (n = 33) of MR imaging was significantly lower, with a detection rate of 9 of 33 for the Dixon sequence and 15 of 33 for the VIBE sequence (P, 0.0001 for VIBE and Dixon sequence). There was a high correlation of pulmonary lesion size of CT versus VIBE (R = 0.97). Conclusion: PET image quality and detection rate of F-18-FDG-positive lung lesions in PET/ MR imaging is equivalent to PET/ CT despite differences in attenuation-correction techniques. Additionally, a high linear correlation coefficient in the SUVs for the PET images from PET/ CT and PET/MR imaging was found. The detection rate of lung lesions can be significantly improved by adding a diagnostic contrast-enhanced VIBE sequence to the PET/MR imaging protocol. However, the detection rate of small lung lesions is still inferior, compared with PET/CT with diagnostic CT of the chest.
引用
收藏
页码:724 / 729
页数:6
相关论文
共 50 条
  • [41] Comparison of the amyloid brain PET/MR to that of simultaneous PET/CT
    Chun, K.
    Kong, E.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 572 - 572
  • [42] FDG-PET/CT Initial and Subsequent Therapy Evaluation Progressing to PET/MR Imaging
    Mosci, Camila
    Davidzon, Guido A.
    Quon, Andrew
    PET CLINICS, 2012, 7 (04) : 369 - +
  • [43] PET Detection Capabilities of Siemens Biograph PET/CT and PET/MR Systems
    Aasheim, L. B.
    Eikenes, L.
    Karlberg, A. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S79 - S80
  • [44] Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging
    Christiaan Schiepers
    Magnus Dahlbom
    European Radiology, 2011, 21 : 548 - 554
  • [45] Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging
    Schiepers, Christiaan
    Dahlbom, Magnus
    EUROPEAN RADIOLOGY, 2011, 21 (03) : 548 - 554
  • [46] Quantitative carotid PET/MR imaging: clinical evaluation of MR-Attenuation correction versus CT-Attenuation correction in F-18-FDG PET/MR emission data and comparison to PET/CT
    Bini, Jason
    Robson, Philip M.
    Calcagno, Claudia
    Eldib, Mootaz
    Fayad, Zahi A.
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 5 (03): : 293 - 304
  • [47] Evaluation of Dixon Sequence on Hybrid PET/MR Compared with Contrast-Enhanced PET/CT for PET-Positive Lesions
    Jeong J.H.
    Cho I.H.
    Kong E.J.
    Chun K.A.
    Nuclear Medicine and Molecular Imaging, 2014, 48 (1) : 26 - 32
  • [48] Characterization of solitary pulmonary lesions with PET/CT in Southern California.
    Schiepers, C
    Yap, CS
    Dahlbom, M
    Auerbach, M
    Silverman, DH
    Phelps, ME
    Czernin, J
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S205 - S205
  • [49] Evaluation of digital PET imaging Vereos PET/CT
    Jaime, Maria
    Botkin, Crystal
    Frye, Sarah
    Muzaffar, Razi
    Osman, Medhat
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [50] A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma
    Husby, Trine
    Johansen, Hakon
    Bogsrud, Trond
    Hustad, Kari Vekseth
    Evensen, Birte Veslemoy
    Boellard, Ronald
    Giskeodegard, Guro F.
    Fagerli, Unn-Merete
    Eikenes, Live
    ANNALS OF HEMATOLOGY, 2022, 101 (05) : 1077 - 1088